Clinical Perspectives

The Clinical Significance of Delta 8,9-Dehydroestrone Sulfate in Treating Menopausal Vasomotor Symptoms*
Wolf Utian, MD, PhD; Veronica A. Ravnikar, MD; Phillip Sarrel, MD; James A. Simon, MD

*Proceedings from a roundtable symposium held in San Diego, California, on September 27, 2005.


Patient Handout: Frequently Asked Questions About Hormone Therapy


[ Home | CME/CE | Product News | Author Guidelines ]
[ Editorial Boards | Reprints/Permissions | Archives | Circulation | Classifieds | Our Services ]


Copyright ©2000-2008 Quadrant HealthCom Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided on femalepatient.com is for educational purposes only. Use of this Web site is subject to the medical disclaimer and privacy policy.